Healthcare Triangle is trading at $0.45, up 7.55% in pre-market; no fresh company-specific announcement explaining the October 14 rise surfaced in search.

  • October 13’s preliminary proxy filing was not linked to the move in available results.
  • The October 1 Nasdaq delisting determination is prior context; the company said it intended to request a hearing, which could stay suspension during panel review.
  • Major indices were modestly higher in supplied context, not clearly explaining the stock-specific gain.